Brandywine Oak Private Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.82M | Sell |
11,196
-22
| -0.2% | -$4.73K | 0.21% | 56 |
|
|
2026
Q1 | $2.44M | Sell |
11,218
-112
| -1% | -$24.8K | 0.21% | 61 |
|
|
2025
Q4 | $2.59M | Sell |
11,330
-101
| -0.9% | -$23K | 0.22% | 57 |
|
|
2025
Q3 | $2.65M | Sell |
11,431
-601
| -5% | -$122K | 0.23% | 57 |
|
|
2025
Q2 | $2.23M | Hold |
12,032
| – | – | 0.21% | 59 |
|
|
2025
Q1 | $2.52M | Sell |
12,032
-9
| -0.1% | -$1.75K | 0.25% | 53 |
|
|
2024
Q4 | $2.14M | Sell |
12,041
-1,465
| -11% | -$269K | 0.21% | 61 |
|
|
2024
Q3 | $2.67M | Buy |
13,506
+57
| +0.4% | +$10.6K | 0.26% | 54 |
|
|
2024
Q2 | $2.31M | Sell |
13,449
-701
| -5% | -$116K | 0.24% | 57 |
|
|
2024
Q1 | $2.58M | Buy |
14,150
+365
| +3% | +$62.9K | 0.27% | 52 |
|
|
2023
Q4 | $2.14M | Sell |
13,785
-329
| -2% | -$48K | 0.24% | 58 |
|
|
2023
Q3 | $2.1M | Sell |
14,114
-12
| -0.1% | -$1.76K | 0.25% | 57 |
|
|
2023
Q2 | $1.9M | Buy |
14,126
+124
| +0.9% | +$18.2K | 0.21% | 63 |
|
|
2023
Q1 | $2.23M | Sell |
14,002
-21
| -0.1% | -$3.21K | 0.26% | 56 |
|
|
2022
Q4 | $2.27M | Sell |
14,023
-1,299
| -8% | -$199K | 0.28% | 54 |
|
|
2022
Q3 | $2.06M | Sell |
15,322
-161
| -1% | -$23.1K | 0.28% | 56 |
|
|
2022
Q2 | $2.37M | Sell |
15,483
-470
| -3% | -$71.8K | 0.3% | 52 |
|
|
2022
Q1 | $2.59M | Buy |
15,953
+32
| +0.2% | +$4.65K | 0.3% | 60 |
|
|
2021
Q4 | $2.15M | Buy |
15,921
+451
| +3% | +$53.3K | 0.24% | 72 |
|
|
2021
Q3 | $1.67M | Buy |
15,470
+832
| +6% | +$95.1K | 0.19% | 81 |
|
|
2021
Q2 | $1.65M | Buy |
14,638
+8,019
| +121% | +$903K | 0.19% | 82 |
|
|
2021
Q1 | $716K | Sell |
6,619
-14
| -0.2% | -$1.5K | 0.11% | 118 |
|
|
2020
Q4 | $710K | Buy |
6,633
+175
| +3% | +$16.8K | 0.11% | 111 |
|
|
2020
Q3 | $565K | Buy |
6,458
+86
| +1% | +$8.1K | 0.09% | 128 |
|
|
2020
Q2 | $625K | Buy |
6,372
+876
| +16% | +$77.1K | 0.11% | 112 |
|
|
2020
Q1 | $418K | Sell |
5,496
-41
| -0.7% | -$3.49K | 0.09% | 128 |
|
|
2019
Q4 | $490K | Buy |
5,537
+7
| +0.1% | +$581 | 0.09% | 113 |
|
|
2019
Q3 | $418K | Buy |
5,530
+1,827
| +49% | +$125K | 0.08% | 123 |
|
|
2019
Q2 | $269K | Buy |
3,703
+37
| +1% | +$2.91K | 0.05% | 178 |
|
|
2019
Q1 | $295K | Sell |
3,666
-1,501
| -29% | -$123K | 0.06% | 158 |
|
|
2018
Q4 | $476K | Buy |
+5,167
| New | +$454K | 0.11% | 100 |
|
Other funds holding ABBV
Brandywine Oak Private Wealth's ABBV Position: Q2 2026 in Review
Brandywine Oak Private Wealth reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $4.73K and leaving 11,196 shares worth $2.82M. The position accounts for 0.21% of the portfolio, ranked #56.
Brandywine Oak Private Wealth first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Brandywine Oak Private Wealth held 11,196 shares of AbbVie worth $2.82M as of Q2 2026.
- Brandywine Oak Private Wealth sold 22 AbbVie shares in Q2 2026, an estimated $4.73K.
- AbbVie made up 0.21% of Brandywine Oak Private Wealth's portfolio in Q2 2026, its #56 holding.
- Brandywine Oak Private Wealth first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Brandywine Oak Private Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.